Harfst & Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,318
Closed -$347K 111
2025
Q1
$347K Sell
4,318
-763
-15% -$63.5K 0.08% 99
2024
Q4
$416K Sell
5,081
-2,948
-37% -$245K 0.09% 66
2024
Q3
$662K Sell
8,029
-5,407
-40% -$404K 0.15% 66
2024
Q2
$943K Sell
13,436
-1,520
-10% -$109K 0.22% 62
2024
Q1
$1.11M Sell
14,956
-21,644
-59% -$1.51M 0.26% 61
2023
Q4
$2.42M Sell
36,600
-685
-2% -$42.9K 0.64% 29
2023
Q3
$2.35M Sell
37,285
-279
-0.7% -$17.4K 0.66% 29
2023
Q2
$2.12M Buy
37,564
+4,372
+13% +$243K 0.57% 41
2023
Q1
$1.92M Buy
33,192
+34
+0.1% +$2.29K 0.55% 32
2022
Q4
$2.4M Buy
33,158
+51
+0.2% +$3.65K 0.69% 19
2022
Q3
$2.01M Buy
33,107
+7,821
+31% +$500K 0.61% 24
2022
Q2
$1.59M Buy
25,286
+629
+3% +$41.6K 0.45% 38
2022
Q1
$1.73M Buy
24,657
+1,150
+5% +$77.8K 0.4% 42
2021
Q4
$1.47M Buy
23,507
+5,356
+30% +$336K 0.37% 51
2021
Q3
$1.12M Buy
18,151
+421
+2% +$25.3K 0.31% 60
2021
Q2
$1.06M Buy
17,730
+1,403
+9% +$88.9K 0.31% 64
2021
Q1
$992K Buy
+16,327
New +$901K 0.3% 65
2017
Q2
Sell
-301
Closed -$14K 265
2017
Q1
$14K Buy
+301
New +$14.3K 0.01% 210

Other funds holding MET

Harfst & Associates's MET Position: Q2 2025 in Review

Harfst & Associates sold out of MetLife (MET) in Q2 2025, closing a stake of 4,318 shares — an estimated $347K sold.

Harfst & Associates first reported a position in MET in Q1 2017 and held it in 18 quarters. The position peaked at $2.42M in Q4 2023. 1,411 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Harfst & Associates reported no remaining MetLife position as of Q2 2025 after selling out during the quarter.
  • Harfst & Associates sold 4,318 MetLife shares in Q2 2025, an estimated $347K.
  • Harfst & Associates first reported a position in MetLife in Q1 2017 and held it in 18 quarters.
  • Harfst & Associates's MetLife position peaked at $2.42M in Q4 2023.
  • 1,411 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Harfst & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.